Remdesivir has already been used in a small number of patients infected with COVID-19, the disease caused by the coronavirus, and it is currently being used in five clinical studies. The drug was originally developed to treat other viruses, such as Ebola, and was tested in animals and in cell cultures in the lab. These experiments created a strong evidence base for the drug's activity, making it possible to run an informed treatment protocol for patients and to scale up the clinical trials.
Read more: STAT Science
EARA News Digest
Translation: Let the Patients Live